Raymond James Financial Inc Beam Therapeutics Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 28,328 shares of BEAM stock, worth $783,269. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,328Holding current value
$783,269% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
240Shares Held
76.3MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$227 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$217 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$211 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$195 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$134 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.95B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...